Baijin Life Science (HKG:1466) completed the allotment and issue of 65,359,433 shares to 20 subscribers at HK$0.48 apiece, raising net proceeds of around HK$31.3 million, a Thursday filing with the Hong Kong bourse said.
The jewelry business will use proceeds from the issue for general working capital.
Price (HKD): $0.70, Change: $+0.020, Percent Change: +2.94%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.